Athira Pharma's stock plummets after disappointing drug trial results By: Puget Sound Business Journal (Seattle) via Business Journals June 22, 2022 at 16:49 PM EDT The company's lead drug didn't produce a significant change in working memory speed or cognition compared with a placebo. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
